Probiotics or have long been the focus of considerable research to demonstrate their potential health benefits including: preventing C. difficile infection, antibiotic-associated diarrhoea and infant eczema. The probiotic drink Actimel (Lactobacillus casei DN-114 001) can help to reduce the amount of time elderly people suffer from common winter infections, according to research recently published in [...]
Boehringer Ingelheim wish to announce that the European Commission has approved Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with: I. manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or, II. type 2 diabetes mellitus with documented target organ damage. Telmisartan, a modern member of the Angiotensin [...]
Boehringer Ingelheim wish to announce that new Mirapexin (pramipexole) prolonged-release, once daily tablet has been granted marketing authorisation by the European Commission in all EU/EEA countries for the treatment of early and advanced idiopathic Parkinson’s disease (PD). Pramipexole has been indicated since 1997 (as an immediate-release tablet) for the treatment of the signs and symptoms [...]
The Irish Medicines Board has recently authorised the following combination products containing perindopril arginine and amlodipine (Acerycal) for the Irish market. Four different strengths of this combination product have been authorised: 5mg perindopril arginine + 5mg amlodipine (Acerycal 5mg/5mg) 5mg perindopril arginine + 10mg amlodipine (Acerycal 5mg/10mg) 10mg perindopril arginine + 5mg amlodipine (Acerycal 10mg/5mg) [...]
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Citalopram hydrobromide eq. to citalopram 40mg. Description: White oval film-coated tablet with a break-line on one side. Presentation: 40mg-28, €27.10. Indication: Major depressive episodes. Pharmacology: Citalopram is a potent inhibitor of serotonin (5-HT)-uptake. Tolerance to the inhibition of 5-HT-uptake is not induced by [...]
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clopidogrel (HCl) 75mg. Description: Pink, round and slightly convex film-coated tablets. Presentation: 28, €33.58. Indications: Prevention of atherothrombotic events in adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than [...]
Company: Bristol-Myers Squibb Pharmaceuticals / AstraZeneca Pharmaceuticals (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Saxagliptin (HCl) 5mg. Description: Pink, biconvex, round, film-coated tablet, with 5 printed on one side and 4215 on the other side. Presentation: 28, €38.47. Indications: Add-on therapy to improve glycaemic control in adults with type 2 diabetes mellitus. [...]
Company: Genzyme Therapeutics. Legal category: Medical device. Active ingredient: Hylan G-F 20, 2ml (Synvisc), 6ml (Synvisc-One). Description: Synvisc: 2.25ml glass syringe containing 2ml hylan G-F 20. Synvisc-One: 10ml glass syringe containing 6ml hylan G-F 20. Presentation: Synvisc: 1, €88; 3, €264. Synvisc-One: 1, €264. Indications: Temporary replacement and supplement for synovial fluid. Pharmacology: Hylan G-F [...]
Clonmel Healthcare wish to inform you that from 1st February 2010 Clonfolic 0.4mg 28 pack will no longer be available as a GMS reimbursable Product. Clonfolic 0.4mg 28 pack will still be available as an OTC product only. Please rest assured that the 98 pack size of Clonfolic 0.4mg remains GMS reimbursable. They hope this [...]
Micardis (telmisartan) is now approved by the European Commission for the reduction of cardiovascular (CV) morbidity in patients with manifest atherothrombotic CV disease or type 2 diabetes with documented target organ damage. This new indication is based on a review of clinical trials, including results from the ONTARGET trial (see New Clinical Evidence section). Telmisartan, [...]
Loading ...
